Mosquito Species, IgE, Serum
Use
This test is useful for establishing a diagnosis of an allergy to mosquito species by defining the allergen responsible for eliciting signs and symptoms. It helps identify allergens responsible for allergic responses or anaphylactic episodes and confirms sensitization prior to beginning immunotherapy. It also aids in the investigation of the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens.
Special Instructions
Not provided.
Limitations
Testing for IgE antibodies is not useful in patients previously treated with immunotherapy to determine if residual clinical sensitivity exists or in patients for whom the medical management does not depend upon identification of allergen specificity. Some individuals with clinically insignificant sensitivity to allergens may have measurable levels of IgE antibodies in serum. False-positive results for IgE antibodies may occur in patients with markedly elevated serum IgE (>2500 kU/L) due to nonspecific binding to allergen solid phases.
New York Approved
Methodology
Immunoassay (Fluorescence Enzyme Immunoassay (FEIA))
Biomarkers
IgE Antibodies
Analyte
LOINC Codes
- 6177-0 - Aedes mosquito IgE Qn
- 6177-0 - Aedes mosquito IgE Qn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL for every 5 allergens requested
Minimum Volume
0.3 mL for 1 allergen
Container
Preferred: Serum gel, Acceptable: Red top
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
Gross hemolysis and gross lipemia conditions are acceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |